Quality & Regulatory Readiness Check
A practical self-assessment for pharma, biotech, medical device and diagnostic teams. Identify unfinished 2026 items, hidden compliance exposure and the areas most likely to create friction in Q1.
What could surprise your team in Q1 2027?
Year-end readiness is more than closing a task list. This check looks across quality systems, inspection readiness, regulatory commitments, supplier oversight, data integrity and validation so you can spot issues that may otherwise carry quietly into the new year.
Tell us what environment you work in
This does not affect your score. It helps make the result more relevant and gives BioBoston useful context if you request a follow-up.
Your provisional readiness score is ready
Enter your work information to unlock the category breakdown, priority flags and recommended next actions.
Readiness overview
Where to focus first
These are the lowest-scoring areas in your self-assessment. Review them before they become schedule, inspection or submission risks.
Need a deeper review?
Use the service most closely connected to the gap you identified.